Additional Information

Description

Atracurium 10 mg/mL in a 5 mL single-dose vial is a non-depolarizing neuromuscular blocking agent used as an adjunct to general anesthesia. It facilitates skeletal muscle relaxation during surgical procedures, mechanical ventilation, and endotracheal intubation. Atracurium works by competitively binding to nicotinic acetylcholine receptors at the neuromuscular junction, preventing acetylcholine from triggering muscle contractions.

The solution is provided in a sterile, preservative-free form and is intended for intravenous administration. Atracurium undergoes Hoffman elimination, a pH- and temperature-dependent process, for metabolism, making it independent of liver or kidney function. This characteristic is particularly beneficial for patients with hepatic or renal impairment, ensuring reliable and consistent effects.

The single-dose vial ensures the sterility and accuracy of dosing, reducing the risk of contamination. Atracurium must be administered by a trained healthcare professional, with appropriate monitoring of neuromuscular function to avoid prolonged paralysis or other complications. The medication is typically administered as part of a balanced anesthesia regimen.